Advertisement
Organisation › Details
PepGen Inc. (Nasdaq: PEPG)
PepGen, Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Deliver Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates that target the root cause of serious diseases. *
Start | 2020-12-09 established (approx) | |
Group | PepGen (Group) | |
Industry | BIOTECH | |
Industry 2 | EDO technology (enhanced delivery oligonucleotides) (PepGen) | |
Person | McArthur, James (PepGen 202102– CEO before RA Capital Management + Imara + Cydan + Vtesse + Tiburio + Nightstar) | |
Person 2 | Godfrey, Caroline (PepGen 201912 CEO + Academic Founder) | |
Region | Cambridge, MA | |
Country | United States (USA) | |
Street | 245 Main Street | |
City | 02142 Cambridge, MA | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | B: 11 to 50 (2022-03-31) |
Currency | USD | |
Profit | -27,281,000 (2021-12-31) | |
Cash | 132,895,000 (2021-12-31) | |
* Document for »About Section«: PepGen, Inc.. (5/5/22). "Press Release: PepGen Announces Pricing of Initial Public Offering". Boston, MA. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for PepGen (Group)
- [1] PepGen, Inc.. (5/5/22). "Press Release: PepGen Announces Pricing of Initial Public Offering". Boston, MA....
- [2] PepGen, Inc.. (10/28/21). "Press Release: PepGen Appoints Noel Donnelly as Chief Financial Officer". Boston, MA....
- [3] PepGen, Inc.. (8/5/21). "Press Release: PepGen Announces Closing of $112.5 Million Crossover Financing to Advance Transformative Therapies for Neuromuscular Diseases". Boston, MA....
- [4] PepGen Ltd.. (2/4/21). "Press Release: PepGen Announces Appointment of James McArthur, Ph.D., as President and Chief Executive Officer". Boston, MA & Oxford....
- [5] PepGen Ltd.. (12/9/20). "Press Release: PepGen Raises $45M Series A". Boston, MA & Oxford....
- [6] PepGen Ltd.. (1/30/20). "Press Release: PepGen Joins Forces with Researchers to Tackle Brain Comorbidity in DMD"....
- [7] PepGen Ltd.. (2/1/19). "Press Release: PepGen’s £1.6M Grant from Innovate UK Has Commenced"....
- [8] PepGen Ltd.. (11/23/18). "Press Release: Damian Marron Appointed as PepGen’s Chairman of the Board"....
- [9] PepGen Ltd.. (11/2/18). "Press Release: PepGen Receives a £1.6M Grant from Innovate UK"....
- [10] PepGen Ltd.. (3/27/18). "Press Release: PepGen Has Launched"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top